1. Home
  2. PKOH vs OBIO Comparison

PKOH vs OBIO Comparison

Compare PKOH & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park-Ohio Holdings Corp.

PKOH

Park-Ohio Holdings Corp.

HOLD

Current Price

$24.34

Market Cap

299.5M

Sector

Industrials

ML Signal

HOLD

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

N/A

Current Price

$4.39

Market Cap

246.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PKOH
OBIO
Founded
1907
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.5M
246.2M
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
PKOH
OBIO
Price
$24.34
$4.39
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$37.00
$14.25
AVG Volume (30 Days)
26.7K
219.9K
Earning Date
03-04-2026
03-12-2026
Dividend Yield
2.06%
N/A
EPS Growth
N/A
33.13
EPS
1.70
N/A
Revenue
$1,599,100,000.00
$33,482,000.00
Revenue This Year
$7.87
N/A
Revenue Next Year
$3.42
$5.20
P/E Ratio
$14.31
N/A
Revenue Growth
N/A
1169.22
52 Week Low
$15.52
$2.20
52 Week High
$29.50
$5.42

Technical Indicators

Market Signals
Indicator
PKOH
OBIO
Relative Strength Index (RSI) 44.99 49.57
Support Level $23.71 $4.02
Resistance Level $29.00 $4.88
Average True Range (ATR) 1.12 0.28
MACD -0.09 -0.02
Stochastic Oscillator 58.54 44.59

Price Performance

Historical Comparison
PKOH
OBIO

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Share on Social Networks: